1. AAEM Quality Assurance Committee, American Association Electrodiagnostic medicine. Practice parameter or repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement. Muscle Nerve, 2001;24:1236-1238.
2. Andews PI, Sanders DB. Juvenile myasthenia gravis. In Neuromuscular Disorders of infancy, Childhood, and Adolescence. Ed Jones HR, DeVivo DC, Darras GT, Butterworth Heinemann, Boston. 2002. pp 575-597.
3. Anlar B, Senbil N, Kose G, et al. Serological follow-up in juvenile myasthenia gravis: clinical and acetylcholine receptor antibody status of patients followed for at least 2 years. Neuromuscular Dis. 2005;15:355-357.
4. Chan KH, Lachance D, lennon V. Definition and frequency of seronegativity in generalized myasthenia gravis acquired in adulthood. Neurology. 2006;66 (Suppl 2):A256.
5. Drachman DB, Jones RJ, Brodksky RA. Treatment of refractory myasthenia. “Rebooting” the immune system with high-dose cyclophosphamide. Neurology: 2002;58 (Suppl 3):A328-329.
6. Engel AG. Congenital myasthenia syndromes. In Neuromuscular function Disorders. Series 3/e, ed Engel AG. Elsever, 2007.
7. Evoli A, Tonali PA, Padua I, Monaco ML, Scuderi F, Batocchi AP , Marino M, Bartoccioni E. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain, 2003;126:2304-2311.
8. Farrugia ME, Robson MD, Clover I, et al. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody associated myasthenia gravis. Brain; 2006;129:1481-1492.
9. Ferrero S, Pretta S, Nicoletti A, et al. Myasthenia gravis management issues during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2005; 121:129-138.+
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.